Pharming Group (OTCMKTS:PHGUF) Sets New 1-Year High – Here’s What Happened

Shares of Pharming Group NV (OTCMKTS:PHGUF) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $1.65 and last traded at $1.65, with a volume of 2800 shares traded. The stock had previously closed at $1.53.

Pharming Group Price Performance

The company has a current ratio of 3.16, a quick ratio of 2.39 and a debt-to-equity ratio of 0.46. The stock has a 50-day moving average price of $1.54 and a 200 day moving average price of $1.34. The stock has a market capitalization of $1.11 billion, a price-to-earnings ratio of 165.17 and a beta of 0.38.

Pharming Group (OTCMKTS:PHGUF) last released its quarterly earnings results on Thursday, November 6th. The biotechnology company reported $0.01 earnings per share for the quarter. The company had revenue of $97.30 million during the quarter, compared to analysts’ expectations of $80.18 million. Pharming Group had a return on equity of 0.46% and a net margin of 0.30%.

Pharming Group Company Profile

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.